| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Aardvark Therapeutics, Inc.
13G
AARD · 002942100
|
9.6% |
2/24/2025
Event 2/12/2025
|
||||
| Dr. Finian Tan | 8.7% | |||||
| Christopher Michael Ho | 7.9% | |||||
| Vickers Venture Fund VI Pte. Ltd. | 9.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.